TACSTD2 and ovarian cancer: Our combined analysis and experimental results suggested that TACSTD2 regulates the PI3K/AKT pathway through the Rap1 signalling pathway in ovarian cancer cells, thereby modulating AKT phosphorylation and influencing the cytotoxicity of platinum-based treatment in ovarian cancer cells.